Thyroid Dysfunction in Pregnancy: Implications for Maternal and Fetal Health

Radiana Torroglosa^*
*Correspondence: Radiana Torroglosa, Department of Obstetrics and Gynaecology, Rey Juan Carlos University, Av. de Atenas, s/n, 28922 Alcorcón, Spain, Email:

Keywords

Thyroid dysfunction • Pregnancy • Hypothyroidism • Hyperthyroidism • Maternal health

Introduction

Thyroid hormones are vital for the regulation of metabolism, growth, and development. During pregnancy, the demand for thyroid hormones increases to support the physiological changes in the mother and the developing fetus. Thyroid dysfunction, including both hypothyroidism and hyperthyroidism, can have significant repercussions for pregnancy outcomes and fetal health. Hypothyroidism, characterized by insufficient thyroid hormone production, Thyroid dysfunction during pregnancy represents a significant concern for both maternal and fetal health, given the thyroid gland's pivotal role in regulating metabolism, growth, and development [1]. Pregnancy imposes unique physiological demands on the thyroid gland, including an increased need for thyroid hormones to support fetal development and maternal metabolic changes. Both hypothyroidism and hyperthyroidism can adversely affect pregnancy outcomes, making accurate diagnosis and effective management crucial. The increased prevalence of thyroid disorders during pregnancy, combined with the potential for both overt and subtle thyroid dysfunction to impact maternal and fetal health, underscores the need for a comprehensive understanding of these conditions and their management. Effective monitoring and treatment of thyroid disorders in pregnant women are essential to optimize outcomes and reduce risks associated with thyroid dysfunction. and hyperthyroidism, marked by excessive hormone levels, can each pose unique risks. This paper explores the implications of thyroid dysfunction in pregnancy, the importance of screening and diagnosis, and the management strategies to mitigate associated risks [2].

Literature Review

Thyroid dysfunction during pregnancy, including hypothyroidism and hyperthyroidism, can lead to various complications for both the mother and the fetus. Hypothyroidism, characterized by insufficient thyroid hormone production, can cause preeclampsia, anemia, miscarriage, preterm birth, and low birth weight. It can also negatively affect fetal brain development, leading to neurodevelopmental delays and cognitive impairments. The most common causes of hypothyroidism in pregnancy include autoimmune thyroiditis (Hashimoto’s disease), iodine deficiency, and previous thyroid surgery. Conversely, hyperthyroidism, marked by excessive thyroid hormone production, poses risks such as preeclampsia, heart failure, preterm birth, and low birth weight [3]. Thyroid hormones are essential for normal fetal development, particularly during the first trimester when the fetus is entirely dependent on maternal thyroid hormones for growth and neurological development. Maternal thyroid function undergoes significant changes during pregnancy due to increased production of thyroid-binding globulin (TBG), which can affect the availability of free thyroid hormones. The physiological changes of pregnancy, including increased blood volume and altered metabolism, also necessitate adjustments in thyroid hormone levels. Hypothyroidism, characterized by insufficient thyroid hormone production, can lead to various complications such as preeclampsia, anaemia, premature birth, and impaired cognitive development in the offspring. Screening and treatment of hypothyroidism are critical to prevent these adverse outcomes.

Conversely, hyperthyroidism, characterized by excessive thyroid hormone levels, poses its own set of risks. The most common form of hyperthyroidism during pregnancy is Graves' disease, an autoimmune condition that can result in symptoms such as weight loss, rapid heartbeat, and excessive sweating. Untreated hyperthyroidism can lead to complications such as preterm birth, low birth weight, fetal tachycardia, and an increased risk of miscarriage. Effective management of hyperthyroidism involves balancing medication to control maternal symptoms while minimizing potential adverse effects on the fetus. Thyroid function tests, including serum TSH (thyroid-stimulating hormone) and free T4 levels, are critical in diagnosing thyroid dysfunction during pregnancy [4]. The reference ranges for thyroid function tests are adjusted during pregnancy to account for the physiological changes that occur. For instance, the normal reference range for TSH is lower in pregnant women compared to non-pregnant individuals. Accurate interpretation of thyroid function tests is essential for proper diagnosis and treatment. In addition to hypothyroidism and hyperthyroidism, subclinical thyroid dysfunction—where thyroid hormone levels are within normal ranges but TSH is abnormal—can also impact pregnancy outcomes. Subclinical hypothyroidism, characterized by elevated TSH with normal free T4 levels, has been associated with increased risks of preterm birth and impaired neurodevelopmental outcomes. Similarly, subclinical hyperthyroidism, characterized by low TSH with normal free T4 levels, may be linked to adverse pregnancy outcomes such as preterm birth and low birth weight.

Management of thyroid dysfunction during pregnancy involves careful monitoring and appropriate treatment to mitigate risks and optimize maternal and fetal health. Treatment typically includes levothyroxine for hypothyroidism and antithyroid medications such as propylthiouracil (PTU) or methimazole for hyperthyroidism. The choice of medication and dosage must be carefully managed to balance the needs of the mother and the fetus while minimizing potential side effects. Regular follow-up and monitoring of thyroid function are essential to ensure adequate control of the condition throughout pregnancy. Fetal complications from maternal hyperthyroidism can include fetal hyperthyroidism, growth restriction, and neurodevelopmental issues [5]. Common causes of hyperthyroidism in pregnancy include Graves’ disease and toxic multinodular goiter. Managing these conditions requires careful balancing of treatments to avoid adverse effects on both the mother and fetus, emphasizing the need for regular monitoring and tailored therapeutic strategies.

Hypothyroidism occurs when the thyroid gland does not produce enough thyroid hormones. During pregnancy, maternal hypothyroidism can lead to various complications, such as preeclampsia, anemia, miscarriage, preterm birth, and low birth weight. The fetus relies on maternal thyroid hormones, especially during the first trimester, for brain development and growth. Untreated maternal hypothyroidism can result in neurodevelopmental delays and cognitive impairments in the child. Causes of hypothyroidism in pregnancy include autoimmune thyroiditis (Hashimoto’s disease), iodine deficiency, and previous thyroid surgery.

Discussion

Thyroid dysfunction during pregnancy necessitates careful monitoring and management due to its potential to significantly impact maternal and fetal health. Early diagnosis through routine screening of thyroid function is crucial, especially for women with known risk factors such as a history of thyroid disease, family history, or symptoms of thyroid dysfunction. For hypothyroidism, treatment typically involves the administration of levothyroxine to normalize thyroid hormone levels. The dosage may need adjustment as pregnancy progresses due to increased hormone requirements. Regular monitoring of thyroid function tests is essential to ensure optimal dosing and to prevent complications [6]. Management of hyperthyroidism during pregnancy is more complex, as treatment must be carefully tailored to avoid fetal and maternal adverse effects. Antithyroid medications such as propylthiouracil and methimazole are commonly used, but they must be administered with caution due to potential teratogenic effects and the risk of fetal hypothyroidism. In some cases, beta-blockers may be used to manage symptoms. Thyroidectomy is rarely performed during pregnancy unless absolutely necessary. The effects of thyroid dysfunction extend beyond pregnancy and can influence long-term maternal and child health.

For instance, children born to mothers with untreated thyroid dysfunction may experience lasting neurodevelopmental issues. Therefore, postpartum monitoring of thyroid function in both the mother and the child is recommended to address any ongoing or emerging health concerns. Thyroid dysfunction during pregnancy presents a multifaceted challenge that requires a nuanced understanding of the physiological changes occurring in the thyroid gland and their implications for maternal and fetal health. Accurate diagnosis and management of thyroid disorders are crucial for optimizing pregnancy outcomes and minimizing risks. The increased prevalence of thyroid dysfunction during pregnancy highlights the importance of early screening and monitoring, particularly for women with risk factors such as a history of thyroid disease, autoimmune disorders, or previous pregnancy complications.

The management of hypothyroidism during pregnancy involves careful titration of levothyroxine to achieve and maintain appropriate thyroid hormone levels. Maternal thyroid function should be monitored regularly to adjust medication dosages as needed and prevent complications associated with both under-treatment and overtreatment. The impact of untreated hypothyroidism on fetal development, particularly cognitive and neurological outcomes, underscores the importance of early and effective treatment. Similarly, the management of hyperthyroidism during pregnancy requires a delicate balance to control maternal symptoms while minimizing potential adverse effects on the fetus. Antithyroid medications, such as PTU and methimazole, are used to manage hyperthyroidism, with PTU preferred during the first trimester due to its lower risk of teratogenic effects. The choice of medication and monitoring of fetal thyroid function are essential to ensure safe and effective treatment.

Subclinical thyroid dysfunction, although often less severe, can also affect pregnancy outcomes and requires careful management. Regular monitoring and appropriate treatment based on clinical guidelines can help mitigate risks and improve outcomes for both mother and baby. Emerging evidence suggests that treatment of subclinical thyroid dysfunction, particularly in high-risk populations, may benefit pregnancy outcomes and reduce the likelihood of complications. The interplay between thyroid dysfunction and other factors, such as maternal age, pre-existing medical conditions, and lifestyle factors, adds complexity to the management of thyroid disorders during pregnancy. Collaborative care involving obstetricians, endocrinologists, and other healthcare professionals is essential for providing comprehensive management and addressing any coexisting conditions that may impact thyroid health.

Conclusion

Thyroid dysfunction in pregnancy presents significant risks to both maternal and fetal health, necessitating early detection, appropriate management, and continuous monitoring. Understanding the impact of conditions such as hypothyroidism and hyperthyroidism on pregnancy outcomes highlights the need for routine thyroid function screening in at-risk populations. Hypothyroidism and hyperthyroidism can both lead to a range of complications, from preterm birth and cognitive impairments to low birth weight and miscarriage. Effective treatment strategies, including appropriate use of levothyroxine for hypothyroidism and antithyroid medications for hyperthyroidism, are crucial for mitigating these risks. Regular follow-up and individualized care are necessary to address the unique needs of pregnant women with thyroid disorders and ensure the health and well-being of both mother and baby. Ongoing research and advancements in the understanding of thyroid function during pregnancy will continue to enhance management strategies and improve outcomes, emphasizing the importance of vigilant monitoring and personalized care in the management of thyroid dysfunction during pregnancy. Effective treatment strategies, tailored to the needs of pregnant women, can mitigate many of the associated risks and promote healthier pregnancy outcomes. On-going research and education are essential to improve clinical practices and ensure that both mother and child achieve optimal health during and after pregnancy.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Setti, Amanda Souza, Daniela Paes de Almeida Ferreira Braga, Livia Vingris and Assumpto Iaconelli, et al. "Improved embryonic development and utilization rates with Embryo Scope: A within-subject comparison versus a bench top incubator." Zygote 30 (2022): 633-637.

Google Scholar, Crossref, Indexed at

2. Barnes, Josue, Matthew Brendel, Vianne R.Gao and Suraj Rajendran, et al. "A non-invasive artificial intelligence approach for the prediction of human blastocyst ploidy: A retrospective model development and validation study." Lancet Digit Health (2023): e28-e40.

Google Scholar, Crossref, Indexed at

3. Alegre, Lucía, Raquel Del Gallego, Sarai Arrones and Purificación Hernández, et al. "Novel noninvasive embryo selection algorithm combining time-lapse morphokinetics and oxidative status of the spent embryo culture medium." Fertil Steril 111 (2019): 918-927.

Google Scholar, Crossref, Indexed at

4. Ng, Shu-Wing, Gabriella A. Norwitz, Mihaela Pavlicev and Tamara Tilburgs, et al. "Endometrial decidualization: The primary driver of pregnancy health." Int J Mol Sci 21 (2020): 4092.

Google Scholar, Crossref, Indexed at

5. Ticconi, Carlo, Nicoletta Di Simone, Luisa Campagnolo and Asgerally Fazleabas. "Clinical consequences of defective decidualization." Tissue and Cell 72 (2021): 101586.

Google Scholar, Crossref, Indexed at

6. Diaz-Gimeno, P., P.Sebastian-Leon, J. M. Sanchez-Reyes and A. Devesa-Peiro, et al. "Identifying and optimizing human endometrial gene expression signatures for endometrial dating." Hum Reprod 37 (2022): 284-296.

Google Scholar, Crossref, Indexed at